August 22-24, 2017

Boston, MA

3D tissue models are set to revolutionize drug discovery and development.

With the promise of faster, more accurate compound screening and greater predictability of safety and efficacy than ever before, they have the potential to transform the way we undertake and understand toxicology, drug metabolism, and PK/PD.

But will they live up to the hype? Can we ever really model the full complexity of the human body ex vivo?

3D Tissue Models 2016 will explore critical questions about the true utility and limitations of these models in pharmaceutical development to help you to overcome key drug development, biological and commercial challenges to achieve rapid success.

Driven by case studies from the pharmaceutical industry, this conference goes beyond the science of tissue engineering. Learn how organ-on-a-chip, organoid and other stem cell derived tissue technologies can be deployed in drug discovery, toxicology, systems pharmacology and DMPK applications to expedite discovery and translation to clinical research.

Read more here.

“Excellent panel of speakers providing a comprehensive overview of the field.”

Vertex Pharmaceuticals, Past Attendee,
Hanson Wade Event

Linkedin red
For more information about 3D Tissue Models email: